Fig. 3From: Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosisMedium chain acylcarnitines C8 and C10 in samples with various underlying MCADD variantsBack to article page